Former Chair of the Council of Economic Advisers Tomas J. Philipson discussed Covid policies and his experience in the Trump administration at a Harvard Undergraduate Economics Association event Wednesday evening. Philipson, currently an emeritus professor of public...
By Tomas Philipson October 24, 2023 More than one year ago, President Biden signed the Inflation Reduction Act (IRA) into law. “His top legislative achievement has many flaws. But by far its most damaging effects will be increased illness and death stemming from...
Bureaucracy didn’t block Covid vaccines. Why should it stand in the way of treatments for cancer, diabetes and other diseases? by Casey B. Mulligan “This year’s Nobel Prize in Medicine honored the groundbreaking work on mRNA that laid the technological...
by Tomas J. Philipson in The National Review Capital Matters “The Inflation Reduction Act’s Medicare price controls create bad incentives for drug development and access. This month, the Biden administration announced the initial ten drugs, of an eventual...
How hard will the Inflation Reduction Act (IRA) hit pharma R&D? Harder than the government expected, according to work (PDF) by the University of Chicago that found lower R&D spending could result in 79 fewer new small-molecule drugs over the next 20 years....
